In its application, Lykos describes MDMA as a catalyst for the therapeutic system, Which explains why it gained a great deal of interest. That's not envisioned being just as much of the hold-up for other psychedelics, nevertheless. “The rest of us are learning molecules that do not demand exactly the same degree of therapy,” states Kabir Nath,